» Articles » PMID: 31623631

Clinical Characteristics of Women Captured by Extending the Definition of Severe Postpartum Haemorrhage with 'refractoriness to Treatment': a Cohort Study

Overview
Publisher Biomed Central
Date 2019 Oct 19
PMID 31623631
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The absence of a uniform and clinically relevant definition of severe postpartum haemorrhage hampers comparative studies and optimization of clinical management. The concept of persistent postpartum haemorrhage, based on refractoriness to initial first-line treatment, was proposed as an alternative to common definitions that are either based on estimations of blood loss or transfused units of packed red blood cells (RBC). We compared characteristics and outcomes of women with severe postpartum haemorrhage captured by these three types of definitions.

Methods: In this large retrospective cohort study in 61 hospitals in the Netherlands we included 1391 consecutive women with postpartum haemorrhage who received either ≥4 units of RBC or a multicomponent transfusion. Clinical characteristics and outcomes of women with severe postpartum haemorrhage defined as persistent postpartum haemorrhage were compared to definitions based on estimated blood loss or transfused units of RBC within 24 h following birth. Adverse maternal outcome was a composite of maternal mortality, hysterectomy, arterial embolisation and intensive care unit admission.

Results: One thousand two hundred sixty out of 1391 women (90.6%) with postpartum haemorrhage fulfilled the definition of persistent postpartum haemorrhage. The majority, 820/1260 (65.1%), fulfilled this definition within 1 h following birth, compared to 819/1391 (58.7%) applying the definition of ≥1 L blood loss and 37/845 (4.4%) applying the definition of ≥4 units of RBC. The definition persistent postpartum haemorrhage captured 430/471 adverse maternal outcomes (91.3%), compared to 471/471 (100%) for ≥1 L blood loss and 383/471 (81.3%) for ≥4 units of RBC. Persistent postpartum haemorrhage did not capture all adverse outcomes because of missing data on timing of initial, first-line treatment.

Conclusion: The definition persistent postpartum haemorrhage identified women with severe postpartum haemorrhage at an early stage of haemorrhage, unlike definitions based on blood transfusion. It also captured a large majority of adverse maternal outcomes, almost as large as the definition of ≥1 L blood loss, which is commonly applied as a definition of postpartum haemorrhage rather than severe haemorrhage.

Citing Articles

Efficacy and Safety Analyses of Recombinant Factor VIIa in Severe Post-Partum Hemorrhage.

Caram-Deelder C, McKinnon Edwards H, Zdanowicz J, van den Akker T, Birkegard C, Blatny J J Clin Med. 2024; 13(9).

PMID: 38731185 PMC: 11084845. DOI: 10.3390/jcm13092656.


Characteristics and treatment for severe postpartum haemorrhage in different midwifery hospitals in one district of Beijing in China: an institution-based, retrospective cohort study.

Yang Y, Shao Y, Chen H, Guo X, Liang Y, Wang Y BMJ Open. 2024; 14(4):e077709.

PMID: 38569676 PMC: 11146356. DOI: 10.1136/bmjopen-2023-077709.


Severe postpartum hemorrhage and the risk of adverse maternal outcome: A comparative analysis of two population-based studies in France and the Netherlands.

de Vries P, Deneux-Tharaux C, Caram-Deelder C, Goffinet F, Henriquez D, Seco A Prev Med Rep. 2024; 40:102665.

PMID: 38435415 PMC: 10907197. DOI: 10.1016/j.pmedr.2024.102665.


A new modified obstetric early warning score for prognostication of severe maternal morbidity.

Xu Y, Zhu S, Song H, Lian X, Zeng M, He J BMC Pregnancy Childbirth. 2022; 22(1):901.

PMID: 36464694 PMC: 9720996. DOI: 10.1186/s12884-022-05216-7.


Effect of Baogong Zhixue Granules Combined with Tranexamic Acid Injection on the Hemodynamics and Reproductive System in Patients with Postpartum Hemorrhage after Cesarean Section.

Cui X, Ji Y, Zhang L, Lv Q, Liu L Evid Based Complement Alternat Med. 2022; 2022:1249779.

PMID: 35722160 PMC: 9203211. DOI: 10.1155/2022/1249779.

References
1.
Joseph K, Rouleau J, Kramer M, Young D, Liston R, Baskett T . Investigation of an increase in postpartum haemorrhage in Canada. BJOG. 2007; 114(6):751-9. DOI: 10.1111/j.1471-0528.2007.01316.x. View

2.
Schaap T, Bloemenkamp K, Deneux-Tharaux C, Knight M, Langhoff-Roos J, Sullivan E . Defining definitions: a Delphi study to develop a core outcome set for conditions of severe maternal morbidity. BJOG. 2017; 126(3):394-401. DOI: 10.1111/1471-0528.14833. View

3.
Zwart J, Dupuis J, Richters A, Ory F, van Roosmalen J . Obstetric intensive care unit admission: a 2-year nationwide population-based cohort study. Intensive Care Med. 2009; 36(2):256-63. PMC: 2809313. DOI: 10.1007/s00134-009-1707-x. View

4.
. Prevention and Management of Postpartum Haemorrhage: Green-top Guideline No. 52. BJOG. 2016; 124(5):e106-e149. DOI: 10.1111/1471-0528.14178. View

5.
Zwart J, Yazdani S, Harvey M, de Vries R, Van Roosmalen J . Underreporting of major obstetric haemorrhage in the Netherlands. Transfus Med. 2009; 20(2):118-22. DOI: 10.1111/j.1365-3148.2009.00967.x. View